BIOLOGIC DRUG CONCENTRATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES ARE NOT ASSOCIATED WITH ANTI-SPIKE IGG TITER LEVEL AFTER MRNA SARS-COV-2 VACCINATION

被引：0
|
作者：
Yarur, Andres
Melmed, Gil
Cedillo Castelan, Viankail O.
Khan, Abdul
Mengesha, Emebet
Debbas, Philip
Hanna, Mary
Ho, Jessica
Braun, Dervieux Jonathan G.
Mcgovern, Dermot P. B.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1751
引用
收藏
页码：S1109 / S1109
页数：1
相关论文
共 50 条
  • [21] POST-VACCINATION SYMPTOMS AFTER A FOURTH DOSE OF MRNA SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Lee, Yoo Jin
    Li, Dalin
    Mujukian, Angela
    Debbas, Philip
    Hampton, Melissa
    Mengesha, Emebet
    Chiorean, Michael V.
    Lum, Donald
    Braun, Jonathan G.
    Mcgovern, Dermot P. B.
    Melmed, Gil
    GASTROENTEROLOGY, 2023, 164 (06) : S532 - S533
  • [22] POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Mujukian, Angela
    Li, Dalin
    Debbas, Philip
    Banty, Andrea
    Feldman, Edward J.
    Ha, Christina
    Lee, Susie
    Rabizadeh, Shervin
    Stein, Theodore
    Solomon, Theodore
    Syal, Gaurav
    Targan, Stephan R.
    Vasiliauskas, Eric A.
    Ziring, David
    Bonthala, Nirupama
    Hampton, Melissa
    Pozdnyakova, Valeriya
    Gu, Phillip
    Ebinger, Joseph
    Joung, Sandy
    Figueiredo, Jane C.
    Merchant, Akil
    Merin, Noah
    Reckamp, Karen L.
    Appel, Keren
    Kumar, Rashmi
    Boland, Brigid
    Charabaty, Aline
    Chiorean, Michael V.
    Cohen, Erica
    Flynn, Ann D.
    Valentine, John F.
    Ehrlich, Adam C.
    Fudman, David
    Glover, Sarah C.
    Horizon, Arash A.
    Karayev, Dmitry
    Kretzmann, Benjamin
    Hou, Jason K.
    Hwang, Caroline
    Lazarev, Mark
    Lum, Donald
    Fausel, Rebecca
    Reddy, Swapna
    McConnell, Ryan
    Mattar, Mark
    Metwally, Mark
    Ostrov, Arthur
    Nimisha, Parekh
    Raffals, Laura H.
    GASTROENTEROLOGY, 2022, 162 (07) : S162 - S163
  • [23] Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination
    Swadzba, Jakub
    Anyszek, Tomasz
    Panek, Andrzej
    Martin, Emilia
    VACCINES, 2021, 9 (11)
  • [24] Evaluation of the Anti-Spike (RDB) IgG Titer among Workers Employed at the University of Pisa Vaccinated with Different Types of SARS-CoV-2 Vaccines
    Foddis, Rudy
    Marino, Riccardo
    Silvestri, Roberto
    Fallahi, Poupak
    Perretta, Salvio
    Garaffa, Christian
    Morganti, Riccardo
    Corsi, Martina
    Mennucci, Jonathan
    Porciatti, Francesco
    Nerli, Gianluca
    Buselli, Rodolfo
    Veltri, Antonello
    Caldi, Fabrizio
    Guglielmi, Giovanni
    Luchini, Grazia
    Briani, Silvia
    Talini, Donatella
    Cipriani, Francesco
    VACCINES, 2022, 10 (08)
  • [25] A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination
    Greene, Sarah E.
    Huang, Yuefang
    Kim, Wooseob
    Liebeskind, Mariel J.
    Chandrasekaran, Vinay
    Liu, Zhuoming
    Deepak, Parakkal
    Paley, Michael A.
    Lew, Daphne
    Yang, Monica
    Matloubian, Mehrdad
    Gensler, Lianne S.
    Nakamura, Mary C.
    O'Hallaran, Jane A.
    Presti, Rachel M.
    Whelan, Sean P. J.
    Buchser, William J.
    Kim, Alfred H. J.
    Weil, Gary J.
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2023, 3 (01):
  • [26] POST-VACCINATION SARS-COV-2 IGG ANTIBODY TITER IN DIALYSIS PATIENTS
    Yoshida, Sumiko
    Tsuji, Seijirou
    Miya, Keiko
    Shima, Hisato
    Tashiro, Manabu
    Inoue, Tomoko
    Minakuchi, Jun
    Okada, Kazuyoshi
    Endo, Itsuro
    Abe, Masahiro
    JOURNAL OF HYPERTENSION, 2023, 41 : E320 - E320
  • [27] Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
    Roberto Stellini
    Renzo Gianello
    Walter Gomarasca
    Infection, 2022, 50 : 1573 - 1577
  • [28] Anti-Spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
    Greenberger, Lee M.
    Saltzman, Larry A.
    Gruenbaum, Lore M.
    Xu, Jun
    Reddy, Sneha T.
    Senefeld, Jonathon W.
    Johnson, Patrick W.
    Fields, Paul A.
    Sanders, Catherine
    DeGennaro, Louis J.
    Nichols, Gwen L.
    BLOOD CANCER DISCOVERY, 2022, 3 (06): : 481 - 489
  • [29] Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder
    Nemani, Katlyn
    De Picker, Livia
    Dickerson, Faith
    Leboyer, Marion
    Santacatterina, Michele
    Ando, Fumika
    Capichioni, Gillian
    Smith, Thomas E.
    Kammer, Jamie
    El Abdellati, Kawtar
    Morrens, Manuel
    Coppens, Violette
    Katsafanas, Emily
    Origoni, Andrea
    Khan, Sabahat
    Rowe, Kelly
    Ziemann, R. Sarah
    Tamouza, Ryad
    Yolken, Robert H.
    Goff, Donald C.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 38
  • [30] Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
    Stellini, Roberto
    Gianello, Renzo
    Gomarasca, Walter
    INFECTION, 2022, 50 (06) : 1573 - 1577
12345